ON DEMAND VIRTUAL POSTER Program

The committee are pleased to announce the ON DEMAND POSTER VIRTUAL Program is now available. This will continue to be updated as more details are confirmed, please note this is subject to change without notice.

The ON DEMAND POSTER VIRTUAL Program will be available to access from the start of the conference, Sunday 30 May 2021. The pre-recorded presentations are available in the On Demand section of the Virtual Portal and can be watched at your leisure. Why not design your own program and add them to your calendar!

Biomedical & Clinical Poster Abstract Presentations

#092 Value of Sofosbuvir/Velpatasvir (SOF/VEL) as pangenotypic panfibrotic hepatitis c virus (HCV) treatment in implementing a test and treat strategy in prisons: real-world care management from 6 countries.

Speaker: Joss O’Loan, Kombi Clinic

#068 PROMPt – Point of care testing for Hepatitis C in the priority settings of mental health, prisons ad drug & alcohol facilities

Speaker: Lucy Ralton, Royal Adelaide Hospital, SA

#099 Time for universal hepatitis B screening for Australian adults

Speaker: Lien Tran, WHO Collaborating Centre For Viral Hepatitis

#027 Testing on the periphery: partnerships for optimising hiv and hepatitis c results delivery for priority populations

Speaker: Aurelie Kenigsberg, NSW Sexual Health Infolink

#066 Continuing workforce education delivery during a pandemic: conversion to online delivery of the HBVs100 prescriber course

Speaker: Rachel Byrne, ASHM

Community & Social Science Poster Abstract Presentations

#071 The Juice: Developing a health promotion resource for people who inject performance and image enhancing drugs

Speaker: Grace Hogan, Hepatitis Australia

#078 Postcards from prison: creating partnerships and innovative health promotion during COVID

Speaker: Ruth Bearpark, Hepatitis NSW

#108 Are you living with Hepatitis B? Find out. Get tested.

Speaker: Ella Negrine, Multicultural HIV and Hepatitis Service, NSW

#073 Ensuring community voices are heard during a pandemic

Speaker: Grace Crowley, Hepatitis NSW

#094 When you don’t speak their lingo? How bi-lingual community health workers can increase the knowledge retention for viral hepatitis

Speaker: Marrianne Black, Ethnic Communities Council of Queensland, QLD

#049 B tested, B vaccinated, B stronger

Speaker: Lana Richardson, Hepatitis Queensland

#041 Looking to community corrections for ‘hardly reached’ HCV patients – a new approach to achieve HCV elimination in Australia

Speaker: Winnie Nguyen, Hepatitis Queensland

#039 Community participation in the time of COVID

Speaker: Neylan Aykut, Liverwell Limited

#056 Digital pathways to HEP C elimination: the Hepconnect program

Speaker: Sandy Davidson, Hepatitis NSW

Epidemiology & Public Health Poster Abstract Presentations

#039 Community participation in the time of COVID

Speaker: Neylan Aykut, Liverwell Limited

#038 Innovative partnership with rotary – “end hepatitis now”

Speaker: Kay Dufty, LiverWELL Limited

#037 Sharing holistic liver health resources for Aboriginal and Torres Strait Islander communities

Speaker: Kay Dufty, LiverWELL Limited

#145 Eliminating hepatitis C in Australia – a successful nurse-led statewide program for hepatitis C treatment in Victorian prisons

Speaker: Michael MacIsaac, St Vincent’s Hospital Melbourne, VIC

#017 “I’ve no money, I’m about to be evicted”: characteristics of clients and utility of receiving copayment support for direct acting antiviral therapy

Speaker: Rosie Gilliver, Kirketon Road Centre, NSW

#114 A successful hepatitis C outreach service in a medically supervised injecting room: increased uptake of screening and high rates of treatment initiation

Speaker: Michael MacIsaac, St Vincent’s Hospital Melbourne, VIC

#028 Nurse led model of care supporting general practitioners in the management of Hepatitis B within Western Sydney

Speaker: Kindness Bondezi, Westmead Hospital, NSW

#021 Autochthonous and travel acquired Hepatitis E Virus in Australia

Speaker: Kathy Jackson, VIDRL, VIC

#064 A modelling analysis of financial incentives for hepatitis c testing and treatment uptake delivered through a community-based testing campaign

Speaker: Anna Palmer, The Burnet Institute, VIC

#081 Clearing the path: a partnership to deliver a communications campaign to increase hepatitis c treatment access for people who inject drugs

Speaker: Maria McMahon, Hepatitis NSW

#019 Post- Vaccination serological outcomes for infants born to women infected with HEPATITIS B

Speaker: Lai Ping Elsa Chu, Royal North Shore Hospital, NSW

#104 Hepatitis C incidence in primary care clinics, Victoria, Australia, 2009 to 2019.

Speaker: Anna Wilkinson, The Burnet Institute, VIC

#115 Awareness of HCV infection status among people who inject drugs in a setting of universal direct-acting antiviral therapy: the ethos engage study

Speaker: Heather Valerio, The Kirby Institute, UNSW, NSW

#124 No evidence of association of methamphetamine injecting on currnet hepatitis c infection: the ethos engage study

Speaker: Heather Valerio, The Kirby Institute, UNSW, NSW

#119 Hepatitis C virus cascade of caare among people who inject drugs in Australia: Factors associated with testing and treatment in a universal healthcare system

Speaker: Olivia Price, National Drug And Alcohol Research Centre

#025 Healthcare Implications of The Epidemiology And Health Literacy For Viral Hepatitis In Culturally and Linguistically Diverse Communities In Australia

Speaker: Belaynew Taye, The University Of Queensland

#129 Hepatitis B and Hepatitis C Policies In The Western Pacific Region: Pregnancy And Paediatrics Gaps

Speaker: Farihah Malik, University College London (UCL)

#140 Impacts of an educational program on hepatitis B testing uptake among ethnic Chinese in Australia: results of a randomised controlled pilot and feasibility study

Speaker: Yinzong Xiao, The Burnet Institute

#139 A systematic review of risk factors for chronic Hepatitis B infection in Chinese adults

Speaker: Elizabeth Hamilton, University Of Oxford

#075 Reaching corners of the yard services cannot: a prison based hepatitis and harm reduction peer education pilot

Speaker: Tom Wright, Justice Health and Forensic Mental Health Network

#122 Opioid overdose and naloxone access among people who recently used opioids or received opioid agonist treatment in Australia: the ETHOS Engage Study

Speaker: Anna Conway, The Kirby Institute, UNSW, NSW

#057 Exploring Hepatitis C Virus Testing and Treatment Engagement In Melbourne, Australia: Baseline Results from the ec Experience Prospective Cohort Study

Speaker: Daniel O’Keefe, The Burnet Institute

#087 A randomised controlled trial of active case management to link hepatitis c notifications to hepatitis c treatment in Tasmania – a study protocol

Speaker: Tafireyi Marukutira, The Burnet Institute

#137 Finding Thousands: Test, Cure, Live National Campaign

Speaker: Wendy Anderson, Hepatitis Australia